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Abstract
Background: Mass spectrometry is an important analytical tool for clinical proteomics. Primarily employed for
biomarker discovery, it is increasingly used for developing methods which may help to provide unambiguous
diagnosis of biological samples. In this context, we investigated the classiﬁcation of phenotypes by applying support
vector machine (SVM) on experimental data obtained by MudPIT approach. In particular, we compared the
performance capabilities of SVM by using two independent collection of complex samples and diﬀerent data-types,
such as mass spectra (m/z), peptides and proteins.
Results: Globally, protein and peptide data allowed a better discriminant informative content than experimental
mass spectra (overall accuracy higher than 87% in both collection 1 and 2). These results indicate that sequencing of
peptides and proteins reduces the experimental noise aﬀecting the raw mass spectra, and allows the extraction of
more informative features available for the eﬀective classiﬁcation of samples. In addition, proteins and peptides features
selected by SVMmatched for 80% with the diﬀerentially expressed proteins identiﬁed by the MAProMa software.
Conclusions: These ﬁndings conﬁrm the availability of the most label-free quantitative methods based on
processing of spectral count and SEQUEST-based SCORE values. On the other hand, it stresses the usefulness of
MudPIT data for a correct grouping of sample phenotypes, by applying both supervised and unsupervised learning
algorithms. This capacity permit the evaluation of actual samples and it is a good starting point to translate proteomic
methodology to clinical application.
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Background
The identiﬁcation of proteins changing their quantitative
level is a key aspect to investigate biological systems as
well as to develop strategies for classifying samples into
pre-speciﬁed categories, such as healthy and diseased. In
fact, one of the main objectives of the clinical proteomics
is to use relevant biomarkers for improving disease diag-
nosis or for monitoring the eﬃcacy of treatments [1].
A procedure for discriminating biological samples
involves a preliminary evaluation of experimental data,
useful for building classiﬁcation models [2]. In this
context, a wide variety of algorithms has been used for
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processing rawmass spectra, mainly generated byMALDI
[3-10] and SELDI technologies [11-14]. Although results
from diagnostic studies based on SELDI have generated
both excitement and scepticism, it doesn’t allows a direct
identiﬁcation of proteins and it is based on m/z sig-
nals, only. On the other hand, MALDI is mainly used
for the identiﬁcation of peptides and its reproducibility
is strongly dependent by sample preparation method.
Besides, inmany studies, selected discriminantmass spec-
trometry signals have then been identiﬁed by liquid chro-
matography (LC) coupled to mass spectrometry (MS).
Nevertheless, few works have directly taken into consid-
eration LC-MS data for discriminating biological samples
[15,16]. On the contrary, some authors have used them,
combined to machine learning algorithms, for improv-
ing tandemmass (MS/MS) spectra quality assessment and
hence, the protein identiﬁcation [17-20].
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Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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Recently, the improvement of robustness and repro-
ducibility of the MudPIT (Multidimensional Protein
Identiﬁcation Technology) approach, based on two
dimensional liquid chromatography coupled to tandem
mass spectrometry, has permitted a correct grouping of
phenotypes, by using unsupervised algorithms [21-23].
Based on these ﬁndings, MudPIT may represent an
attractive methodology for improving methods con-
cerning sample classiﬁcation. It allows to automatically
obtain thousands of features comprising spectra, peptide
sequences and related proteins [24,25]. In addition, label-
free quantiﬁcation approaches based on spectral count
(SpC) or SEQUEST-based SCORE evaluation permit
an high-throughput discovering of multiple biomarkers
[26-28], which could contain a higher level of discrimina-
tory information.
The present study investigates in-depth the availability
of MudPIT data for the classiﬁcation of biological sam-
ples. We focused on classiﬁcation performances achiev-
able by processing diﬀerent data-types, such as spectra,
peptides and proteins. Speciﬁcally, we applied a class of
machine learning algorithms, i.e. Support VectorMachine
(SVM), to identify most predictive features and to score
the data-types according to the inference performances
of the algorithm [29,30]. Finally, since the identiﬁcation
of features allowing a model of classiﬁcation is a key
challenge for high-dimensional data, we evaluated how
the applied selection method correlates with an inde-
pendent label-free quantiﬁcation approach. Therefore, we
measured the overlapping of the features selected by
SVMwith the diﬀerentially expressed proteins selected by
means of the MAProMa software [31].
Methods
Data collections
For the study purpose, two pre-existing diﬀerent collec-
tions of experimental data were used. They were previ-
ously obtained by means of MudPIT analysis of complex
samples, such as the adipose and cardiac tissues, collected
according to the acquisition of the informed consent of
patients, and the ethical approval of protocols for the care
and use of laboratory animals, as reported by Brambilla
et al. [32] and Simioniuc et al. [23], respectively. Speciﬁ-
cally, for collection 1 were considered 30 diseased and 11
healthy controls, while 18 diseased and 18 healthy con-
trols were considered for collection 2 (Additional ﬁle 1:
Figure S1). Experimental details of the MudPIT analysis
are reported in Additional ﬁle 2.
Data handling of MS results
Raw mass spectra (MS) produced by MudPIT were han-
dled using MZmine software [33]. Peak detection was
performed by the chromatogram builder module by using
the Centroid algorithm. Each ﬁle containing MS spectra
was processed individually and converted to pairs of m/z
and intensity values by considering all data points above
the speciﬁed noise level (e3). Then, m/z data points were
connected to form chromatograms. In particular, themin-
imum time span was set to 1 min, the minimum absolute
height to e3 and them/z tolerance to 0.5. Finally, peak lists
were aligned by Join aligner method applying a ranges of
tolerance of 0.5 and 1 min for mass and retention time,
respectively.
The experimental tandem mass spectra (MS/MS) were
correlated to in-silico tryptic peptide sequences, and
accordingly to parent proteins, by using a database search
method based on the SEQUEST algorithm [34]. The
validity of spectrum/peptide matching was assessed using
SEQUEST deﬁned parameter thresholds (Additional
ﬁle 2). Finally, protein and peptide lists obtained from
each sample were handled and aligned using MAProMa
software and an in-house R-script, respectively [31,35].
In order to evaluate the reproducibility of the Mud-
PIT approach, protein lists of technical replicates were
aligned and then processed using a linear-regression-
based analysis:
Yi = β0 + β1Xi + ui
where:
i = 1, ........, n; with n = number of variables (proteins)
Yi is the spectral count (SpC) value of the protein i in the
ﬁrst replicate analysis
Xi is the spectral count (SpC)) value of the protein i in the
second replicate analysis
β0 is the intercept of the regression line of the population
β1 is the slope or gradient of the regression line of the pop-
ulation
ui is the error term
Proteomic datasets
Each sample belonging to the collection 1 and 2 was repre-
sented by ﬁve diﬀerent datasets, including the global pro-
tein/peptide proﬁles and m/z precursor ions from three
diﬀerent chromatographic steps (60, 120, 400 mM) of the
applied analytical method (Additional ﬁle 2). Each dataset
was formatted in a s × f matrix, where s represents the
number of samples and f the number of features. Entries
of the protein data matrix were the spectral count (SpC)
values assigned by the SEQUEST algorithm to each iden-
tiﬁed protein; in the same way, Xcorrelation values and
peak area intensity (AUC) were used for the peptide and
mass spectra data matrices, respectively (Additional ﬁle 3:
Table S1).
Label-free quantiﬁcation approach
Proteins diﬀerentially expressed between the considered
phenotype groups were identiﬁed by using a label-free
quantiﬁcation approach. In particular, SEQUEST-based
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SCORE values were processed by means of the DAve and
DCI formulas, which are inserted in MAProMa software
[31]. In addition, SpC values were evaluated by using the
G-test [36] and the unpaired Student’s t-test. In this sce-
nario, proteins with DAve ≥ 0.3 (≤ −0.3) and DCI ≥
300 (≤ −300), or statistical meaningful at least for one
test (P > 95%) were considered for the study purpose
(Additional ﬁle 2 and Additional ﬁle 4: Figure S2).
Evaluation procedures by SVM
In order to investigate on the classiﬁcation performance
achievable by the diﬀerent data-types (spectra, peptides
and proteins) we designed speciﬁc RapidMinerworkﬂows
(RM-WF) mainly addressed to implement a class of algo-
rithms widely used in the machine learning community,
i.e., the Support Vector Machine (SVM) [30].
In our investigation we sequentially applied two main
operational processes i.e., feature selection and model
construction (and validation), respectively. We brieﬂy
summarize in the following issues the RM-WF designed
for each phase (a complete description of each operator is
reported in Additional ﬁle 5: Figure S3).
1. Feature selection phase. Due to the high number of
signals, features selection may be helpful to improve
both the inference quality and the data
understanding. For this reason we ﬁrst applied a
standard feature selection procedure [29]. Broadly
speaking we weighted each signal by an information
theory criterion (i.e., info–gain ratio [37]). Then we
considered to employ in the forward phase only
signals having a weight greater than 0.6; this way,
only 10 signals were considered. The RM-WF in this
case is simple, providing only the info–gain
weighting capability as reported in Additional ﬁle 5:
Figure S3 (a).
2. Model construction and validation phase. To
evaluate the classiﬁcation performance achievable by
the diﬀerent data-types, we employed SVM
algorithms as “black boxes” to score each input
data-type, according to the inference performances
of the algorithm [29]. In order to avoid over-ﬁtting
we ﬁrst sub-sampled a set of diﬀerent data instances:
i.e., for each data set, this phase was applied on (data)
instances never used in the above feature selection
step. Then, for each instance, we considered only
intensity (and counting) values corresponding to the
previously suggested 10 signals (i.e., feature
selection). This approach has been applied together
with an optimization procedure to learn the
algorithm parameters. As a matter of fact, diﬀerent
learning model may have many parameters, and
often it is not clear which values are best for the
learning task at hand; in our case, SVMs involve
diﬀerent kernel types and, in turn, each of such
functions uses speciﬁc values which we need to
deﬁne in the learning algorithms [30]. In order for
the SVMs to perform as better (and homogeneous)
as possible for each data-type, we optimized such
parameters over the same space of common values.
That is, we searched the best parameter values (i.e.,
providing the highest SVM inference performances)
among all the combinations of common ranges for
each input data collection. The RM-WF reported in
Additional ﬁle 5: Figure S3 (b) speciﬁes the main
steps used in this phase.
Finally, standard indices (i.e., sensitivity, speciﬁcity, pos-
itive (PPV), negative predictive (NPV), accuracy, F-score,
balanced accuracy, informedness and Matthews correla-
tion coeﬃcient) were used as performance measures to
verify which data-types provide the best SVM classiﬁca-
tion [2].
Results and discussion
In this study, we investigated the classiﬁcation of phe-
notypes by applying support vector machine (SVM)
algorithms on experimental data obtained by MudPIT
approach (Figure 1). Identiﬁed proteins, peptides and
experimental mass spectra (m/z) were processed to evalu-
ate the generalization capability of SVM about the disease
vs. healthy cases used in this study (Additional ﬁle 1:
Figure S1). For this purpose, a RapidMiner workﬂow was
implemented (Additional ﬁle 4: Figure S3). Firstly, a set
of data was used as input to SVM learning algorithm.
Some learning parameters were optimized over the same
common space of values [30]. Finally, data were evaluated
according to the inference performance of the algorithm
by using standard indices broadly applied to measure the
precision and the recall capability [2].
By applying a standard features selection procedure, ten
features having a weight greater than 0.6 were selected
from each dataset (see features selection phase in Materi-
als and Methods). Model delivered by the SVM operator
was applied on independent validation datasets for esti-
mating the performances concerning the phenotype clas-
siﬁcation. Tables 1 and 2, reporting the standard indices,
show the diagnostic capabilities of SVM by using two
independent collection of samples and diﬀerent data-
types. Of note, the results suggest that SVMallows a better
classiﬁcation capability by using proteins and peptides
rather than mass spectra datasets. In fact, better values of
accuracy, F-score, informedness and MCC were observed
by considering both collection 1 and collection 2. As
opposite, samples classiﬁcation by means of m/z data,
resulted to be more diﬃcult. In particular, by using the
mass spectra of the collection 1 low values of speciﬁcity
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Figure 1MudPIT workﬂow. Enzymatic digested peptides are ﬁrst separated by Strong Cation Exchange (SCX), using steps of increasing salt
concentration, followed by Reverse Phase (RP) chromatography, using an acetonitrile gradient. Eluted peptides are then directly analyzed by
tandemmass spectrometry producing MS and MS/MS spectra. By speciﬁc algorithm, such as SEQUEST, and applying appropriate criteria of data
ﬁltering (see Additional ﬁle 2), the comparison of experimental MS and MS/MS spectra with those in-silico predicted from a protein sequence
database allows the characterization of the peptide sequences and the corresponding proteins, without limits of isoelectric point (pI), molecular
weight (Mw) or hydrophobicity. Using MudPIT, ﬁve diﬀerent datasets per sample were collected for the study purposes. Speciﬁcally, in addition to
complete protein and peptide proﬁles,m/z data, corresponding to 60 mM, 120 mM, 400 mM of salt concentration steps, were mined collecting
three diﬀerent datasets of spectra.
were observed, while the mass spectra of the collection 2
allowed low overall classiﬁcation accuracy values.
The diﬀerent classiﬁcation performances, obtained by
SVM, may be related to the m/z data complexity. In this
regard, an overview of the data was performed by means
of Principal Component Analysis (PCA) [38]. As opposed
to protein and peptide data, PCA showed that mass spec-
tra, especially for the collection 1, didn’t allow a clear
diﬀerentiation in themultidimensional space between dis-
ease and healthy groups (Additional ﬁle 6: Figure S4).
In this context, the great amount of mass spectra can
make it diﬃcult their data-mining. In fact, a single step
Table 1 Performance of classiﬁcation obtained by using SVM - Collection1
Spec. Sens. PPV NPV Acc. F-score Bal. Acc. Informedness MCC
Proteins 75% 91% 75% 91% 87% 0.46 83% 67% 0.66
Peptides 75% 100% 100% 92% 94% 0.48 88% 75% 0.72
m/z-DB1 50% 96% 80% 85% 84% 0.45 72% 46% 0.43
m/z-DB2 75% 96% 86% 92% 90% 0.47 85% 71% 0.69
m/z-DB3 37% 100% 100% 83% 84% 0.45 68% 37% 0.34
Speciﬁcity (Spec.), sensitivity (Sens.), positive predictive value (PPV), negative predictive value (NPV), accuracy (Acc.), F-score, balanced accuracy (Bal. Acc.),
informedness and Matthews correlation coeﬃcient (MCC) of collection 1. Evaluation capabilities have been obtained using observations not considered in the signal
selection phase.
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Table 2 Performance of classiﬁcation obtained by using SVM - Collection2
Spec. Sens. PPV NPV Acc. F-score Bal. Acc. Informedness MCC
Proteins 93% 93% 93% 93% 93% 0.46 92% 85% 0.85
Peptides 100% 100% 100% 100% 100% 0.50 100% 100% 1
m/z-DB1 62% 92% 89% 71% 77% 0.40 77% 54% 0.47
m/z-DB2 77% 77% 77% 77% 77% 0.38 77% 54% 0.54
m/z-DB3 85% 85% 85% 85% 85% 0.42 84% 70% 0.69
Speciﬁcity (Spec.), sensitivity (Sens.), positive predictive value (PPV), negative predictive value (NPV), accuracy (Acc.), F-score, balanced accuracy (Bal. Acc.),
informedness and Matthews correlation coeﬃcient (MCC) of collection 2. Evaluation capabilities have been obtained using observations not considered in the signal
selection phase.
of liquid chromatography separation allows the collec-
tion of a number of features (m/z values) about 15 and 3
times bigger than protein and peptide ones, respectively
(Figure 2). This great amount of data may be due to the
redundant acquisition of spectra, like so to the biological
and/or chemical modiﬁcations of peptides/proteins (e.g.
Post Translational Modiﬁcations). Moreover, m/z values
may be aﬀected by chemical noise as well as to day-to-
day instrument variations. Therefore, preprocessing of the
raw data signiﬁcantly inﬂuences the quality of the classiﬁ-
cation results [39,40]. Nevertheless, further errors may be
introduced during spectra alignment, while overlapping
of m/z regions may create ambiguities for peak detection
leading to increase the noise and to loss of information
and discriminatory ability.
The identiﬁcation of peptides and proteins by means
of the interpretation of tandem mass spectra, can repre-
sent a cleaning and a simplifying of m/z data complexity.
This aspect probably improved the features selection pro-
cess and consequently the performance of classiﬁcation
by means of SVM model. For each collection about 20%
of the selected features resulted common between pro-
tein and peptide datasets. Besides, around 80% of proteins
and peptides, selected by SVM,matched with the diﬀeren-
tially expressed proteins selected by MAProMa software
(Figure 3). This correspondence represents a mutual vali-
dation of these two diﬀerent procedures and it means that
diﬀerentially expressed proteins may be used also for a
correct grouping of sample phenotypes. For this reason,
the use statistical parameters associated with identiﬁed
proteins and peptides represents a robust procedure for
a rapid extraction of potential biomarkers. In addition,
MudPIT approach allows a good analytical reproducibil-
ity (Figure 4). In fact, although only 60-80 % of protein are
identiﬁed in two replicate analyses, most of the variation
is due to low abundance proteins which are usually identi-
ﬁed with a low number of peptides. However, a statistical
model has been proposed for estimating the number of
replicates required for saturated sampling of a complex
protein mixture [41].
Our ﬁndings are in good agreement with the most
widely used semi-quantitative methods concerning the
Figure 2 Features selected for the study purposes. Number of features (m/z ions, peptides and proteins) collected analyzing, by MudPIT, all
samples belonging to collection 1 and collection 2. DB1, DB2 and DB3 correspond tom/z data mined from 60 mM, 120 mM, 400 mM of salt
concentration steps, respectively.
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Figure 3 DAve values for proteins and peptides selected by SVM. DAve evaluates changes in protein expression and is deﬁned as:
((X − Y)/(X + Y))/0.5, while DCI, which describes the conﬁdence of diﬀerential expression, is deﬁned as: (X + Y) ∗ (X − Y))/2, where X and Y
represent the SEQUEST-based SCORE values (or spectral count) of a given protein in two compared samples. Conventionally, signs (+/-) of DAve
(and DCI) indicate if proteins are up-regulated in the ﬁrst or in the second sample, respectively.
identiﬁcation of biomarkers using LC-MS/MS approach
[25,27]. As for the identiﬁcation of clinically useful
biomarkers, in the last decade, SELDI-TOF analysis has
been widely used and many diseases have been mainly
studied by serum/plasma protein proﬁling. Although pre-
liminary results have generated a lot of expectations, later
scepticism resulted prevalent [42]. The reasons of this
failure is probably due to SELDI proﬁling based on m/z
signals, only, and it doesn’t permits a direct identiﬁca-
tion and quantiﬁcation of peptides/proteins. In addition,
blood samples, although relatively simple to be collected,
have a very complex composition with the presence of
prominent and unspeciﬁc changes, resulting a drawback
for the biomarker discovery based on m/z signals. On the
Figure 4MudPIT repeatability. Linear regression analysis obtained by considering SpC values of proteins identiﬁed in two technical replicates of
MudPIT analysis. R2 and Slope values resulted near to 1. Red rectangle highlights the proteins identiﬁed with a low number of peptides and which
represent the portion of data less reproducible.
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contrary, we have evidenced in the present manuscript
the improved availability of peptide/protein outcomes to
allow biomarker discovery and phenotype discrimination.
In comparison to mass spectra, sequenced proteins and
peptides are less aﬀected by experimental errors, and their
use can be useful to avoid the problems of reproducibil-
ity due to diﬀerent instrumental settings occurring over
time. In addition, model of healthy/disease tissues repre-
sents a source of biomarkers in higher concentration than
to plasma, which may be considered mainly useful in their
monitoring using other LC-MS procedures [43].
Conclusion
To realize the potential of MS-based proteomics in the
context of clinical utility, for disease diagnosis and prog-
nosis, comparative studies are of great importance. In
the present work, MudPIT data, both experimental mass
spectra and sequenced peptides/proteins, were processed
by SVM for evaluating the corresponding performances
of classiﬁcation. The overall accuracy resulted in all
investigated cases higher than 77%. In particular, pro-
teins/peptides allowed a better discriminant informative
content than experimental mass spectra (overall accu-
racy higher than 87% in both collection 1 and 2). This
result is probably due to the translation of mass spec-
tra to peptides/proteins, that eliminates the experimen-
tal noise and highlight the actual features useful for the
phenotype classiﬁcation. Overall, the presented ﬁndings
indicate that the impressive amount of data produced by
MudPIT approach can be processed for identifying mul-
tiple biomarkers and for classifying biological samples, by
applying both supervised and unsupervised algorithms.
These procedures permit the evaluation of actual samples
and translate proteomic methodology to clinical applica-
tion. In this context, MudPIT approach can be a useful
tool for improving the extraction of informative features
and therefore diagnosis procedures. Probably, in the next
future new and more eﬃcient algorithms will be applied,
and the discovered biomarkers will be validated by means
of fast and high-resolution mass spectrometry and data
independent analysis [44,45]. These aspects will be of pri-
mary importance to be combined with clinical data and
for investigating mechanisms of pathogenesis. In fact, the
improved quality of data has the potential to optimize
existing protein quantiﬁcation methods and address the
increasing demand of systems biology studies for correlat-
ing molecular expression to biological processes.
Additional ﬁles
Additional ﬁle 1: Supplementary Figure S1 (PNG ﬁle format)—
Sample collections and related experimental data selected and used
for the study purpose. For each sample ﬁve diﬀerent datasets were used.
In addition to the global protein and peptide proﬁles, m/z precursor ions,
speciﬁcally detected from the chromatographic steps corresponding to 60,
120 and 400 mM of ammonium chloride concentration, were considered.
They cover the central part of the salt gradient elution range (0-700mM)
and assure the identiﬁcation of most of the peptides.
Additional ﬁle 2: Supplementary Information (PDF ﬁle format).
Additional ﬁle 3: Supplementary Table S1 (PNG ﬁle format)—Matrix
of high-dimensional proteomic data obtained analyzing sample by
means of the MudPIT approach. Rows represent features (e.g., m/z
values, peptides or proteins), while columns indicate samples. In each cell it
is reported a value corresponding to the parameter associated with
feature. In particular, peak area intensity (AUC) was used form/z mass
points, Xcorrelation (Xcorr) values for peptides and spectral count (SpC)
values for proteins.
Additional ﬁle 4: Supplementary Figure S2 (PNG ﬁle format)— Venn
diagram. Venn diagram of diﬀerentially expressed proteins identiﬁed in
collection 1 (A) and collection 2 (B). Evaluation of quantitative level was
performed by applying DAve and DCI formulas, G-test and Student’s t-test.
In brackets is reported the number of proteins matching with the features
selected by SVM.
Additional ﬁle 5: Supplementary Figure S3 (PNG ﬁle format)— Rapid
Miner workﬂow. Rapid Miner WF for the Feature selection (a) and model
construction/validation (b) phases. Blocks correspond to simple processes
in the whole design: each operator receives an input and delivers an
output to the forward operator. The function of each block is shortly
reported as follow:
• Input Operator reads data from ﬁles.
• Info GainWeighting Operator (Fig. a). Each signal is weighted by
an information theory criterion (i.e., info–gain ratio). The forward
phase (Fig. b) employees only signals having weight greater then 0.6;
• Cross Validation Operator encapsulates a cross validation (k–fold)
process [37]: the input data set S is split up into subsets {S1, S2, ..., Sk}.
The inner operators are applied k times using at each iteration i the
set Si as the test set and S\Si as the training set.• Parameter Optimization Operator In order for the SVMs to
perform as better (and homogeneous) as possible for each datatype,
we optimized the learning parameters over the same space of
common values. That is, starting from common ranges (for every
datatypes the same ranges of values are used) this operator ﬁnds the
optimal combination (i.e., providing the highest SVM inference
performance) of parameter values by using a cross validation process.
Here, we brieﬂy report the applied common ranges for the selected




– SVM.kernel.degree ∈ {2, . . . , 6},
– SVM.C, SVM. ∈ {1, 1.5, . . . , 8}.
• Training SVMOperator implements a Support Vector Machine
algorithm to deliver an inference model.
• Model Applier Operator applies the model delivered by the SVM
operator.
• Performance Operator collects the performance evaluation of the
classiﬁcation task and outputs performance measures.
Additional ﬁle 6: Supplementary Figure S4 (PNG ﬁle format)—
Principal Component Analysis of peptide, protein andm/z, data of
collection 1 and 2. Overview of protein, peptide and mass spectra data
matrices performed by Principal Component Analysis (PCA) (15). PCA was
applied by RapidMiner software. High-dimensionality of each data matrix
was preliminarily reduced by eliminating features identiﬁed with an
identiﬁcation frequency (IF) below a certain threshold. In detail, for protein
and peptide datasets were retained features with IF > 1, while concerning
mass spectra datasets were retained features with IF > 4. Finally, the
principal components that account for most of the variation (PC1-PC2-PC3)
in the original multivariate data were plotted in themultidimensional space.
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